Topical alkane vapocoolant spray versus subcutaneous lignocaine injection for reducing the pain of intravenous cannulation: a randomised, controlled, clinical trial

Phase 4

Completed

• Conditions: Pain of intravenous cannulation; Anaesthesiology - Anaesthetics

• Registration Number: ACTRN12608000414314
• Lead Sponsor: Austin Health

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2008-08-22
• Last Update Posted: 13 January 2020

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 220

Inclusion Criteria

Emergency department patients, aged 18 years or more, requiring intravenous cannulation

Exclusion Criteria

Refusal to provide consent
Inability to provide informed consent (Non-English speaking, altered mental state, significant illness, urgent need for IV cannulation)
Moderate to severe discomfort or pain
Diseases of the skin associated with cold intolerance (eg: Raynaud’s)
Known allergy to spray contents or lignocaine
Peripheral neuropathy
Parenteral analgesia in the previous 4 hours
Use of other local anaesthetics

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Pain score of intravenous cannulation (0-100) on a visual analogue scale[one minute after cannulation]

Secondary Outcome Measures

Name	Time	Method
Thrombophlebitis, blistering, frostbite, redness and swelling at the cannulation site[5 days after cannulation]